RNS
ECYT

Robert N. Shapiro’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Robert N. Shapiro’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-943
Closed -$22K – 816
2014
Q1 		$22K Sell
943
-943
-50% -$13.7K ﹤0.01% 577
2013
Q4 		$20K Buy
1,886
+136
+8% +$1.5K ﹤0.01% 588
2013
Q3 		$23K Buy
+1,750
New +$27.7K ﹤0.01% 769

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Robert N. Shapiro's ECYT Position: Q2 2014 in Review

Robert N. Shapiro sold out of Endocyte, Inc. Common Stock (ECYT) in Q2 2014, closing a stake of 943 shares — an estimated $22K sold.

Robert N. Shapiro first reported a position in ECYT in Q3 2013 and held it in 3 quarters. The position peaked at $23K in Q3 2013. 101 funds tracked by Wall St. Rank hold ECYT as of Q2 2014.

  • Robert N. Shapiro reported no remaining Endocyte, Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
  • Robert N. Shapiro sold 943 Endocyte, Inc. Common Stock shares in Q2 2014, an estimated $22K.
  • Robert N. Shapiro first reported a position in Endocyte, Inc. Common Stock in Q3 2013 and held it in 3 quarters.
  • Robert N. Shapiro's Endocyte, Inc. Common Stock position peaked at $23K in Q3 2013.
  • 101 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q2 2014.

Based on Robert N. Shapiro's 13F filing for Q2 2014, filed 11 Sep 2014.